Elevai Labs, Common Stock Annual Yield
| ELAB Stock | 2.09 0.10 5.03% |
Elevai Labs, Common fundamentals help investors to digest information that contributes to Elevai Labs,'s financial success or failures. It also enables traders to predict the movement of Elevai Stock. The fundamental analysis module provides a way to measure Elevai Labs,'s intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Elevai Labs, stock.
Elevai | Annual Yield |
Elevai Labs, Common Company Annual Yield Analysis
Elevai Labs,'s Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Elevai Annual Yield Driver Correlations
Understanding the fundamental principles of building solid financial models for Elevai Labs, is extremely important. It helps to project a fair market value of Elevai Stock properly, considering its historical fundamentals such as Annual Yield. Since Elevai Labs,'s main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Elevai Labs,'s historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Elevai Labs,'s interrelated accounts and indicators.
Click cells to compare fundamentals
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
| Competition |
In accordance with the recently published financial statements, Elevai Labs, Common has an Annual Yield of 0.0%. This indicator is about the same for the Health Care Equipment & Supplies average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Elevai Annual Yield Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Elevai Labs,'s direct or indirect competition against its Annual Yield to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Elevai Labs, could also be used in its relative valuation, which is a method of valuing Elevai Labs, by comparing valuation metrics of similar companies.Elevai Labs, is currently under evaluation in annual yield category among its peers.
Elevai Fundamentals
| Return On Equity | -3.51 | ||||
| Return On Asset | -0.89 | ||||
| Profit Margin | (1.92) % | ||||
| Operating Margin | (2.32) % | ||||
| Current Valuation | 130.64 K | ||||
| Shares Outstanding | 3.07 M | ||||
| Shares Owned By Insiders | 72.97 % | ||||
| Shares Owned By Institutions | 18.19 % | ||||
| Number Of Shares Shorted | 2.62 M | ||||
| Price To Book | 0.75 X | ||||
| Price To Sales | 2.61 X | ||||
| Revenue | 1.71 M | ||||
| EBITDA | (4.27 M) | ||||
| Net Income | (4.3 M) | ||||
| Total Debt | 210.49 K | ||||
| Book Value Per Share | 0.22 X | ||||
| Cash Flow From Operations | (4.56 M) | ||||
| Short Ratio | 0.17 X | ||||
| Earnings Per Share | (88.92) X | ||||
| Number Of Employees | 18 | ||||
| Market Capitalization | 6.45 M | ||||
| Total Asset | 5.19 M | ||||
| Retained Earnings | (7.02 M) | ||||
| Working Capital | 3.62 M | ||||
| Net Asset | 5.19 M |
About Elevai Labs, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Elevai Labs, Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Elevai Labs, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Elevai Labs, Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Elevai Labs, Common offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Elevai Labs,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Elevai Labs, Common Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Elevai Labs, Common Stock:Check out Elevai Labs, Piotroski F Score and Elevai Labs, Altman Z Score analysis. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Elevai Labs,. If investors know Elevai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Elevai Labs, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (88.92) | Revenue Per Share 0.168 | Quarterly Revenue Growth 0.913 | Return On Assets (0.89) | Return On Equity (3.51) |
The market value of Elevai Labs, Common is measured differently than its book value, which is the value of Elevai that is recorded on the company's balance sheet. Investors also form their own opinion of Elevai Labs,'s value that differs from its market value or its book value, called intrinsic value, which is Elevai Labs,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Elevai Labs,'s market value can be influenced by many factors that don't directly affect Elevai Labs,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Elevai Labs,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Elevai Labs, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Elevai Labs,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.